Literature DB >> 20831296

Perspective and desire in comparative effectiveness research: the relative unimportance of mere preferences, the central importance of context.

Anthony J Culyer1.   

Abstract

Economists engaged in comparative effectiveness research (CER) commonly adopt particular value judgements that underpin many of their methods. Two of these are the idea of a 'societal perspective' and that the foundation of values in measures of health outcome is individual preferences. This article takes issue with both value judgements and argues instead that the values to be adopted are not ones to be determined a priori or independently of the context of the analysis. Indeed, the first task of analysts is to discover these values by early and ongoing consultation with the commissioners of the CER. The same arguments apply to the practice of cost-effectiveness analysis.

Mesh:

Year:  2010        PMID: 20831296     DOI: 10.2165/11535270-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  15 in total

1.  Discounting and health benefits.

Authors:  M Parsonage; H Neuburger
Journal:  Health Econ       Date:  1992-04       Impact factor: 3.046

2.  Discounting and decision making in the economic evaluation of health-care technologies.

Authors:  Karl Claxton; Mike Paulden; Hugh Gravelle; Werner Brouwer; Anthony J Culyer
Journal:  Health Econ       Date:  2010-05-12       Impact factor: 3.046

3.  Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion.

Authors:  Karl Claxton; Mark Sculpher; Anthony Culyer; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier
Journal:  Health Econ       Date:  2006-01       Impact factor: 3.046

4.  Research, public policymaking, and knowledge-translation processes: Canadian efforts to build bridges.

Authors:  John N Lavis
Journal:  J Contin Educ Health Prof       Date:  2006       Impact factor: 1.355

5.  Welfarism vs. extra-welfarism.

Authors:  Werner B F Brouwer; Anthony J Culyer; N Job A van Exel; Frans F H Rutten
Journal:  J Health Econ       Date:  2007-11-29       Impact factor: 3.883

6.  Welfarism, extra-welfarism and capability: the spread of ideas in health economics.

Authors:  Joanna Coast; Richard D Smith; Paula Lorgelly
Journal:  Soc Sci Med       Date:  2008-07-25       Impact factor: 4.634

7.  Discounting costs and effects: a reconsideration.

Authors:  B A van Hout
Journal:  Health Econ       Date:  1998-11       Impact factor: 3.046

8.  Evaluation of neonatal-intensive-care program.

Authors:  J C Sinclair; G W Torrance; M H Boyle; S P Horwood; S Saigal; D L Sackett
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

9.  Eliciting public preferences for healthcare: a systematic review of techniques.

Authors:  M Ryan; D A Scott; C Reeves; A Bate; E R van Teijlingen; E M Russell; M Napper; C M Robb
Journal:  Health Technol Assess       Date:  2001       Impact factor: 4.014

10.  Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence.

Authors:  Anthony Culyer; Christopher McCabe; Andrew Briggs; Karl Claxton; Martin Buxton; Ron Akehurst; Mark Sculpher; John Brazier
Journal:  J Health Serv Res Policy       Date:  2007-01
View more
  3 in total

1.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Comparative effectiveness and child health.

Authors:  Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 3.  Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.

Authors:  Joel P Thompson; Amir Abdolahi; Katia Noyes
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.